Cost-effective diagnostics Emphasize Great Basin Scientific's value-driven pricing and quick, multi-pathogen test capabilities to position as a cost-saving partner for healthcare providers seeking faster, comprehensive infectious disease diagnosis.

Edge in infectious diseases Leverage the chip-based, sample-to-result technology and existing product launches like Bordetella Direct Test and Staph ID/R panels to target buyers seeking advanced molecular diagnostics with streamlined workflows.

Strategic markets Target clinics and labs in the US and Europe where CE Marked tests are already available, focusing on expanding through distributors and partnerships to accelerate market reach for multiplex panels.

Growth potential With funding of approximately $96M and revenue in the low-to-mid millions, there is clear investment readiness for channel expansion, clinical validation partnerships, and scaled manufacturing to meet demand.

Talent and partnerships Highlight the company as a premium employer in Utah to attract top talent and explore collaborations with large-scale manufacturers and distributors in the medical diagnostics space to extend product adoption.